Natural anti-GBM antibodies from normal human sera recognize α3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease

被引:37
|
作者
Yang, Rui
Cui, Zhao
Hellmark, Thomas
Segelmark, Marten
Zhao, Ming-hui [1 ]
Wang, Hai-yan
机构
[1] Peking Univ, Inst Nephrol, Peking Univ Hosp 1,Minist Hlth China, Dept Med,Renal Div,Key Lab Renal Dis, Beijing 100034, Peoples R China
[2] Lund Univ, Dept Nephrol, SE-22184 Lund, Sweden
关键词
natural anti-GBM antibody; antigen specificity; epitope mapping;
D O I
10.1016/j.clim.2007.05.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-GBM disease is a rare autoimmune condition characterized by autoantibodies targeting the alpha 3 chain non-collagen 1 domain of type IV collagen (alpha 3(IV)NC1). Recently, we isolated IgG reacting with alpha 3(IV)NC1 from normal healthy human sera. The current study examined the antigen and epitope specificity of these natural autoantibodies (NAA) using recombinant human alpha 1, 3, 5(IV)NC1 and three constructs expressing, previously defined epitope regions designated E-A, E-B and S2, in the alpha 1(IV)NC1 background. The NAA preparations reacted with recombinant human alpha 3(IV) NC1 to the same extent as with purified bovine alpha(IV)NC1, but not with recombinant human alpha 1 and alpha 5 (IV)NC1. NAA preparations recognized the three chimeric proteins (E-A, E-B and S2) yielding similar absorbance values. We conclude that anti-GBM NAA recognize the same major epitopes as anti-GBM antibodies from patients with Goodpasture's disease. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:207 / 212
页数:6
相关论文
共 50 条
  • [1] Relationship between anti-GBM antibodies and kidney outcomes in patients with anti-GBM disease
    Mengyue Zhu
    Jingjing Wang
    Weibo Le
    Feng Xu
    Ying Jin
    Chenfeng Jiao
    Haitao Zhang
    Journal of Nephrology, 2023, 36 : 789 - 797
  • [2] Relationship between anti-GBM antibodies and kidney outcomes in patients with anti-GBM disease
    Zhu, Mengyue
    Wang, Jingjing
    Le, Weibo
    Xu, Feng
    Jin, Ying
    Jiao, Chenfeng
    Zhang, Haitao
    JOURNAL OF NEPHROLOGY, 2023, 36 (03) : 789 - 797
  • [3] HISTOLOGICAL AND CLINICAL ANTI-GBM DISEASE WITH MPO-ANCA BUT WITHOUT CIRCULATING ANTI-GBM ANTIBODIES
    Kirk, Michelle
    Assante, William
    Atemnkeng, Francis
    Mittal, Amol
    Kapoor, Aromma
    Coritsidis, George
    Pullman, James
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S29 - S29
  • [4] Antibodies: Still important in anti-GBM disease
    Turner, AN
    NEPHRON CLINICAL PRACTICE, 2003, 94 (03): : C51 - C52
  • [5] Anti-GBM disease with positive serum anti-GBM antibodies but negative IgG deposition: A case report
    Kazemzadeh, Kimia
    Naeini, Elham Kabiri
    Moeinzadeh, Firouzeh
    Naimi, Azar
    SAGE OPEN MEDICAL CASE REPORTS, 2023, 11
  • [6] Comparison of anti-GBM antibodies in sera with or without ANCA
    Hellmark, T
    Niles, JL
    Collins, AB
    McCluskey, RT
    Brunmark, C
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 (03): : 376 - 385
  • [7] High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to α3(IV)NC1 collagen
    Rutgers, A
    Meyers, KEC
    Canziani, G
    Kalluri, R
    Lin, J
    Madaio, MP
    KIDNEY INTERNATIONAL, 2000, 58 (01) : 115 - 122
  • [8] C3 DOMINANT MPGN AND ANTI-GBM GLOMERULONEPHRITIS WITH NEGATIVE ANTI-GBM ANTIBODIES: A RARE COMBINATION.
    Meouchy, Joseph
    Adenuga, Gbemisola
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (05) : A73 - A73
  • [9] CHARACTERIZATION OF THE NC1 DOMAIN OF COLLAGEN TYPE-IV IN GLOMERULAR BASEMENT-MEMBRANES (GBM) AND OF ANTIBODIES TO GBM IN A PATIENT WITH ANTI-GBM NEPHRITIS
    THORNER, PS
    BAUMAL, R
    EDDY, A
    MARRANO, P
    CLINICAL NEPHROLOGY, 1989, 31 (03) : 160 - 168
  • [10] ANTI-GBM DISEASE (AGBMD) WITHOUT CIRCULATING ANTI-GBM: THREE CASE REPORTS AND THE REVIEW FROM THE LITERATURE
    Carlassara, Lucrezia
    Tardanico, Regina
    Bracchi, Martina
    Colturi, Carla
    Zubani, Roberto
    Gregorini, Gina
    RHEUMATOLOGY, 2017, 56 : 83 - 83